Moreover, CLL cells (n = 15) were stimulated with ET-1 in combination with an agonist specific for toll-like receptor 9 (TLR9) (CpG oligonucleotides) for 5 days. Here, TLR9 is linked to B-cell chronic lymphocytic leukemia.